​

LAVA Therapeutics (LVTX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

LVTX Stock Forecast

LAVA Therapeutics (LVTX) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 358.02% increase from the last price of $1.31.

- $1 $2 $3 $4 $5 $6 High: $6 Avg: $6 Low: $6 Last Closed Price: $1.31

LVTX Stock Rating

LAVA Therapeutics stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (50.00%), 3 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 3 3 Strong Sell Sell Hold Buy Strong Buy

LVTX Price Target Upside V Benchmarks

TypeNameUpside
StockLAVA Therapeutics358.02%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$6.00
Last Closing Price$1.31$1.31$1.31
Upside/Downside--358.02%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-13--4
May, 25-13--4
Apr, 25-13--4
Mar, 25-13--4
Feb, 25112--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 28, 2024Arthur HeH.C. Wainwright$6.00$1.88219.15%358.02%
Mar 20, 2024Roger SongJefferies$6.00$3.0795.44%358.02%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 28, 2024H.C. WainwrightBuyBuyhold
Sep 27, 2022SVB LeerinkOutperformOutperformhold
Sep 16, 2022JMP SecuritiesMarket Performinitialise

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.14$-1.23$-1.57$-0.94----
Avg Forecast$-1.98$-1.18$-1.64$-1.11$-1.31$-0.62$-0.46$-0.46
High Forecast$-1.98$-1.18$-0.98$-0.92$-1.23$-0.35$-0.33$-0.46
Low Forecast$-1.98$-1.18$-2.29$-1.48$-1.38$-0.97$-0.53$-0.46
Surprise %8.08%4.24%-4.27%-15.32%----

Revenue Forecast

$0 $6M $12M $18M $24M $30M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.35M$19.39M$6.77M$11.98M----
Avg Forecast$4.39M$22.24M$5.82M$7.48M$9.65M$11.53M$3.80M$25.16M
High Forecast$4.39M$22.24M$12.40M$7.48M$9.65M$11.53M$3.80M$25.16M
Low Forecast$4.39M$22.24M$2.53M$7.48M$9.65M$11.53M$3.80M$25.16M
Surprise %21.78%-12.80%16.30%60.15%----

Net Income Forecast

$-65M $-53M $-41M $-29M $-17M $-5M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-42.35M$-31.91M$-41.97M$-25.11M----
Avg Forecast$-53.03M$-31.61M$-38.14M$-24.75M$-35.53M$-17.58M$-11.51M$-12.19M
High Forecast$-53.03M$-31.61M$-26.09M$-24.59M$-32.97M$-9.36M$-8.80M$-12.19M
Low Forecast$-53.03M$-31.61M$-61.20M$-39.50M$-36.95M$-25.80M$-14.23M$-12.19M
Surprise %-20.14%0.94%10.05%1.48%----

LVTX Forecast FAQ

Is LAVA Therapeutics stock a buy?

LAVA Therapeutics stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that LAVA Therapeutics is a favorable investment for most analysts.

What is LAVA Therapeutics's price target?

LAVA Therapeutics's price target, set by 6 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 358.02% change from the previous closing price of $1.31.

How does LAVA Therapeutics stock forecast compare to its benchmarks?

LAVA Therapeutics's stock forecast shows a 358.02% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for LAVA Therapeutics over the past three months?

  • June 2025: 0% Strong Buy, 25.00% Buy, 75.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 25.00% Buy, 75.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 25.00% Buy, 75.00% Hold, 0% Sell, 0% Strong Sell.

What is LAVA Therapeutics’s EPS forecast?

LAVA Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.31, marking a 39.36% increase from the reported $-0.94 in 2024. Estimates for the following years are $-0.62 in 2026, $-0.46 in 2027, and $-0.46 in 2028.

What is LAVA Therapeutics’s revenue forecast?

LAVA Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $9.65M, reflecting a -19.43% decrease from the reported $11.98M in 2024. The forecast for 2026 is $11.53M, followed by $3.8M for 2027, and $25.16M for 2028.

What is LAVA Therapeutics’s net income forecast?

LAVA Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-35.529M, representing an 41.47% increase from the reported $-25.114M in 2024. Projections indicate $-17.578M in 2026, $-11.514M in 2027, and $-12.19M in 2028.